מבירט - Maviret

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)

J05AP
Antivirals for treatment of HCV infections

××¨××× ×¤×¢×× (ATC5)

Glecaprevir 100 MG âJ05AP57
Pibrentasvir 40 MG âJ05AP57

×¦××¨×ª ××ª×

×¤××× - PER OS

×¦××¨×ª ××× ××

××××××ª ××¦××¤××ª ×¤×××, FILM COATED TABLETS
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Maviret is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults and in adolescents aged 12 to <18 years

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

11/01/2018

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª

×©××××© ××¡×

××¡××¨×ª ××××× ××¡×

×. ××ª×¨××¤× ×ª×× ×ª× ××××¤×× ×××¤×××××¡ C ××¨×× ××ª ×× ××××¤ 1 ×× 2 ×× 3 ×× 4.

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 13.09.2021

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 30.06.2021 ×¢××× ××¦×¨×× ×¢×¨×××ª 30.06.2021 ×¢××× ××¦×¨×× ×× ××××ª 30.06.2021 ×¢××× ××¦×¨×× 30.06.2021

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××××¨× ×××××¨ ××©×¨× ×××¨××××ª ××××¨× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	ABBVIE DEUTSCHLAND GMBH & CO. KG, GERMANY
×©× ××¢× ××¨××©××	ABBVIE BIOPHARMACEUTICALS LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 7/2017. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

השינוי האחרון נעשה בֹ־17 במאי 2022 ב־07:39

מבירט - Maviret

ויקיתרופות